FGDCX
Price
$52.46
Change
+$0.62 (+1.20%)
Updated
Jun 2 closing price
Net Assets
4.23B
INIYX
Price
$29.25
Change
+$0.38 (+1.32%)
Updated
Jun 2 closing price
Net Assets
1.55B
Interact to see
Advertisement

FGDCX vs INIYX

Header iconFGDCX vs INIYX Comparison
Open Charts FGDCX vs INIYXBanner chart's image
FGDCX vs INIYX Comparison Chart in %
View a ticker or compare two or three
VS
FGDCX vs. INIYX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGDCX is a Hold and INIYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FGDCX has more cash in the bank: 4.23B vs. INIYX (1.55B). INIYX pays higher dividends than FGDCX: INIYX (5.44) vs FGDCX (4.68). FGDCX was incepted earlier than INIYX: FGDCX (19 years) vs INIYX (16 years). FGDCX (1.69) is less costly to investors than INIYX (1.03). FGDCX is a more actively managed with annual turnover of: 60.00 vs. INIYX (30.00). FGDCX has a lower initial minimum investment than INIYX: FGDCX (0) vs INIYX (1000). INIYX annual gain was more profitable for investors over the last year : 76.16 vs. FGDCX (57.95). INIYX return over 5 years is better than : 167.03 vs. FGDCX (101.94).
FGDCXINIYXFGDCX / INIYX
Total Expense Ratio1.691.03164%
Annual Report Gross Expense Ratio1.691.03164%
Fund Existence19 years16 years-
Gain YTD3.6876.41457%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.23B1.55B273%
Annual Yield % from dividends4.685.4486%
Returns for 1 year57.9576.1676%
Returns for 3 years166.43225.7974%
Returns for 5 years101.94167.0361%
Returns for 10 years179.26328.0255%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHSTX61.19N/A
N/A
Putnam Global Health Care A
GCTIX59.94N/A
N/A
Goldman Sachs US Tax-Managed Eq Instl
RFNEX105.27N/A
N/A
American Funds Fundamental Invs R4
DTCYX21.45N/A
N/A
BNY Mellon Sust US Equity Y
LSFLX15.76N/A
N/A
Lord Abbett Focused Large Cap Value R4